Dr Nausheen Ahmed

Consultant Physician · Section Head of Hematology

Cleveland Clinic Abu Dhabi

Abu Dhabi, UAE

At the 1st Emirates Hematology Forum, 31 October 2026

Speaker · 09:35–09:50
CAR-T Cell Therapy in Multiple Myeloma: From Ide-cel to Cilta-cel and Emerging Cellular Therapies
Session: Rewriting the Myeloma Playbook
Panelist · 10:05–10:35
Panel Discussion: Optimal Duration of Maintenance Therapy in Frontline Multiple Myeloma: When, If Ever, Should We Stop? · Sequencing of Therapies in Second Line: CAR-T then BiTEs or BiTEs then CAR-T
Session: Rewriting the Myeloma Playbook

To correct or remove this profile, write to secretariat@eora.ae.